We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA, Generic Firms Will Use Phone, Email to Communicate
FDA, Generic Firms Will Use Phone, Email to Communicate
February 24, 2006
The FDA will start communicating with generic drug applicants via telephone instead of by letter whenever possible, to speed up drug application reviews and whittle down the application backlog, according to Gary Buehler, director of the agency’s Office of Generic Drugs (OGD).